Navigation Links
Pathfinder Initiates Minimally Invasive Surgical Navigation Study
Date:11/15/2010

NASHVILLE, Tenn., Nov. 15, 2010 /PRNewswire/ -- Pathfinder Therapeutics, Inc. has initiated a clinical study to assess the value of Explorer™, its image-guided surgical platform, in minimally invasive liver resections and ablations.  Clinical sites participating in the study include: Memorial Sloan-Kettering Cancer Center, University of Pittsburgh Medical Center, Providence Portland Medical Center, and UNC-Chapel Hill.

Minimally invasive procedures are performed through a few small incisions rather than one large incision.  As a result, these techniques can significantly reduce postoperative pain and patient recovery time compared with traditional surgery.

"We are excited to partner with these highly-regarded institutions to build upon the success of previous clinical studies showing that Explorer™ can provide accurate instrument tracking and guidance during open liver procedures. Despite its known benefits, minimally invasive liver surgery has not attained widespread use, in part due to the advanced skills and technological experience required to perform such procedures safely.  Explorer™ combines state-of-the-art surgical navigation and 3D visualization of preoperative imaging, thereby facilitating the transition from standard techniques to novel laparoscopic techniques for surgeons with less experience and formal training while also providing assistance to highly experienced surgeons," said Skip Goode, CEO of Pathfinder.

As part of the study, preoperative CT or MR imaging is registered to the intraoperative position of the liver, providing surgeons with enhanced visualization of the liver anatomy as well as real-time positioning of surgical instruments, including resection and ablation devices.  Rather than guess where underlying vessels and tumors are, surgeons can be confident they are precisely targeting the anatomical structures they have planned on, thus minimizing costly mistakes which can increa
'/>"/>

SOURCE Pathfinder Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD
2. American Regent Initiates Voluntary Recall of Magnesium Sulfate Injection, USP 50% (25 grams/50 mL), 50mL Single Dose Vial Lot # 0491
3. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
4. Shionogi-ViiV Healthcare LLC Initiates Phase III Clinical Programme for Investigational Once-Daily HIV Integrase Inhibitor
5. Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinsons Disease
6. Max Neeman International Initiates Large Phase IV Trial on Type II Diabetes with 25,000 Subjects Across 1,200 Sites
7. Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)
8. Echo Therapeutics Initiates Needle-Free Biosensor Program for Continuous Lactate Monitoring
9. LigoCyte Pharmaceuticals Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine
10. ISTA Pharmaceuticals Initiates Phase 3 Clinical Program for REMURA™ in Dry Eye Disease
11. N30 Pharma Initiates Phase 1 Trials of Novel Reductase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Mich. , Aug. 22, 2014  Dr. ... Who with the Diamond Lifetime Achievement Award in the ... as CEO of Cardiovascular Clinical Associates. Dr. ... in managing all major aspects of the business; overseeing ... well as primary coronary intervention. In addition, he is ...
(Date:8/22/2014)... Zacks Equity Research highlights Epizyme (Nasdaq: EPZM - Free ... PNRA - Free Report ) as the Bear of the ... (Nasdaq: FOLD - Free Report ), Sanofi (NYSE: SNY ... Report ). Here is a synopsis of all five ... The biotech bull market is far from over due ...
(Date:8/22/2014)... ITHACA, N.Y. , Aug. 22, 2014 /PRNewswire/ ... computed tomography (CT) imaging facility, is using the ... 4D and even 5D imaging to researchers and ... just launched, asks "What would YOU do if ... the possibility to researchers and explorers everywhere, from ...
Breaking Medicine Technology:Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 2Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 3Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 4Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 5Epizyme, Panera, Amicus Therapeutics, Sanofi and Shire highlighted as Zacks Bull and Bear of the Day 6Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2
... Eli Lilly and Company (NYSE: LLY ) will ... on Wednesday, April 25, 2012.  Lilly will also conduct a ... media to further detail the company,s financial performance. ... to 10:00 a.m. EDT.  Investors, media and the general public ...
... Inc. , a biopharmaceutical company focused on the discovery, ... is in the human nervous system, today announced that ... the treatment of cough has cleared the 30 day ... (FDA).  The Company plans to immediately characterize the pharmacokinetics ...
Cached Medicine Technology:Cerecor Announces Clearance of IND for FP01 2
(Date:8/22/2014)... The improved access to antiretroviral drugs ... developing world, has led to the decline in the ... due to AIDS globally. However, despite the fact that ... patients becoming affected by the virus is on the ... all related organisations and stakeholders, by 2015, significant investments ...
(Date:8/22/2014)... A national leader in home delivery of ... room to grow. , Headquarters for the provider of sterile-use ... building at 8516 N.W. Expressway in Oklahoma City. , ... Oklahoma’s best places to work by OKCBiz magazine – demanded ... 120 in the past two years, and staff count grew ...
(Date:8/22/2014)... 2014 (HealthDay News) -- People who use reduced-nicotine cigarettes ... levels of nicotine, according to a new study. ... other smokers, the researchers say. The month-long study ... smoked regular cigarettes with nicotine emission levels of 1.2 ... switched to reduced-nicotine cigarettes for the next three weeks. ...
(Date:8/22/2014)... years, several breakthrough treatments have become available for ... benefit from these treatments can be pre-identified by ... For example, patients whose lung cancer is driven ... benefit from the drug crizotinib, which targets this ... to replicate this success by matching different drugs ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Ticket Down ... tickets in Kalamazoo, New Orleans, Albuquerque and Rapid City. ... the “Long Island Medium,” Theresa Caputo, allows just that. Caputo ... She is part of a close knit family who began ... with a spiritual healer, realized she had a chance to ...
Breaking Medicine News(10 mins):Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Fast-growing 180 Medical Moves Into New 60,000-square-foot Office in Oklahoma City 2Health News:Low-Nicotine Cigarettes May Not Lead to More Smoking 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 3Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 4Health News:Theresa Caputo Tickets in Kalamazoo at Wings Stadium, Saenger Theatre in New Orleans, Kiva Auditorium in Albuquerque and Rapid City at Don Barnett Arena Now Available 2
... likely than Caucasians and men to undergo bone marrow ... the conclusion of a new analysis published early online ... American Cancer Society. The study,s results indicate that additional ... access to bone marrow transplantation and also that the ...
... ... ... Readers will be struck by the illuminative work of a mature poet as author Brad ... its name, this reflective anthology reveals the profound emotions and sentiments of a man who, ...
... “The reviews were amazing. ... BMEGateway to give a symposium to our loyal client base that was enjoyable and memorable on ... like this.” , ... (PRWEB) May 23, 2010 -- BMEGateway, the national leader in independent medical evaluation, peer/medical review ...
... people to protect their ears when going to firework displays, ... most common sounds of summer can expose listeners to permanent ... was sounded by David Coffin, director of Ball State University,s ... come in the form of the pop of fireworks, the ...
... ... celiac disease , ... (PRWEB) May 22, 2010 -- LoveToKnow, Inc. has launched a new Web site channel that ... addition, as part of a campaign to help people with these issues, the company said ...
... ... residential solar energy systems in Bensalem, Pennsylvania. The systems are the first operating systems ... the region. The projects were primarily funded through the Pennsylvania Sunshine Fund and Federal ... West Chester, ...
Cached Medicine News:Health News:African-Americans and women are less likely to undergo bone marrow transplantation 2Health News:The Heart of the Prisoner Revealed 2Health News:BMEGateway's 20th Anniversary Insurance Symposium considered a “Tremendous” Success 2Health News:Summer Sounds Can Lead to Hearing Loss 2Health News:LoveToKnow.com Launches Gluten Free Channel and Will Donate to National Foundation for Celiac Awareness 2Health News:LoveToKnow.com Launches Gluten Free Channel and Will Donate to National Foundation for Celiac Awareness 3Health News:Pennsylvania's Newest Power Companies Right in Your Neighbor's Back Yard 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: